We found a novel peptide that stimulates neurite outgrowth in Neuro-2a mouse neuroblastoma cells, from the pepsin-pancreatin digest of bovine -casein. The amino acid sequence of this peptide is Phe-Leu-ProTyr-Pro-Tyr (FLPYPY), corresponding to peptidic sequence 76-81 of bovine -casein. The neurite outgrowth-stimulating activity of FLPYPY was seen over 10 À9 M. On the other hand, FLPYP and FLPYPYY, which corresponded to sequences 76-80 and 76-82 of bovine -casein respectively, were ineffective.
Previously we reported that -casomorphins (-CMs) derived from bovine -casein have neurotrophic activity. -CMs stimulate neurite outgrowth in Neuro-2a mouse neuroblastoma cells, 1, 2) and promote survival of primary-cultured chick embryonic dorsal root ganglion neurons.
3) These findings led us to reinvestigate other neurotrophic peptides in the enzymatic digest of casein. In this report, we found a novel peptide that stimulates neurite outgrowth in Neuro-2a cells, from the digest of -casein by gastrointestinal proteases.
In order to study neurite outgrowth-stimulating activity, bovine caseins were digested with gastrointestinal proteases. The caseins were digested by the method of Jinsmaa and Yoshikawa. 4) Briefly, casein, -, -, and -casein (Sigma, St. Louis, MO, U.S.A.) solutions (each 24 mg/ml) were adjusted to pH 2.0 with hydrochloric acid and digested with pepsin (Sigma) at an enzymesubstrate ratio (E/S) of 1% (wt/wt) for 5 h at 37 C. The reaction was stopped by adjusting the pH to 7.0 with sodium hydroxide. The caseins or the pepsin digests were hydrolyzed by pancreatin (Sigma) at an E/S of 2% (wt/wt) for 5 h at 37 C, and the reaction was stopped by boiling for 15 min.
The effects of the casein digests by pepsin, pancreatin, or both on the neurite outgrowth in Neuro-2a cells were measured by the method described previously.
2) Figure 1 shows the effects of each digest, equivalent to 200 g casein. Significant stimulating effects were found in the pepsin-pancreatin digests, but not in the pepsin or pancreatin digests. Among the pepsin-pancreatin digests, stimulating effects were found in the digests of -and -casein, but not in that of -casein. -CMs, which have been found by us to have neurite outgrowth-stimulating activity, 2) are known to be released from -casein by pepsin-pancreatin-leucine aminopeptidase (LAP) in vitro.
4) The role of LAP in the release of -CMs is the removal of valine from the amino terminus of the -CM precursor, Val--CMs, in pepsin-pancreatin digest. Hence the reason for the ineffectiveness of -casein digest is unclear, but one hypothesis is that -CMs may be absent in the digest due to the disuse of LAP in this study.
Since the pepsin-pancreatin digest of -casein induced the most potent effect (Fig. 1) , we implemented the isolation of the active peptide in its digest. Purification of the active peptide was carried out by reversed-phase HPLC. 2 mg of the hydrolysate was applied to the ODS column (L-Column ODS, 10 Â 250 mm, Chemicals Evaluation and Research Institute, Japan), and eluted
Fig. 1. Effects of Digests of Caseins by Gastrointestinal Proteases on
Neurite Outgrowth in Neuro-2a Cells. Cells were treated with each digest for 4 h. The numbers of neurite-bearing cells were counted. Data are represented as the mean AE SEM from four observations. The solid horizontal line and dashed lines indicate the mean and SEM of control untreated with a digest respectively. *P < 0:05, **P < 0:01 vs. control (Scheffe's test).
with a linear gradient of 0 to 40% acetonitrile containing 0.1% trifluoroacetic acid (TFA) at 2 ml/min. Each fraction was dried with a centrifugal concentrator and the neurite outgrowth-stimulating activities were measured. The stimulatory activities were eluted at about 35% acetonitrile (elution time 41-42 min) (Fig. 2) . Then the active fraction was further fractionated with another ODS column (Inertsil-ODS, 4:6 Â 250 mm, GL Science, Japan) with an isocratic elution with 22% acetonitrile containing 0.1% TFA at 1 ml/min. The stimulatory activity was eluted at 23.5 min. Finally, the active peptide was purified with a C8 silica column (Bondasphere C8, 3:9 Â 150 mm, Waters, Japan) with a linear gradient of 10 to 30% acetonitrile containing 0.1% TFA at 1 ml/min. The active peptide was eluted at about 24.5% acetonitrile. The purified peptide was analyzed with a protein sequencer (Procise 491HT, Applied Biosystems) and a MALDI-TOF Mass spectrometer (Voyager 4340, Applied Biosystems). The sequence of this peptide was Phe-Leu-Pro-Tyr-ProTyr (FLPYPY, ½M þ H þ m=z 799), corresponding to peptidic sequence 76-81 of bovine -casein. The yield of this peptide from the digest of -casein was 0.073% (0.73 mg/g).
The time course of neurite outgrowth was analyzed in FLPYPY (10 À6 M)-treated and untreated Neuro-2a cells (Fig. 3A) . The neurite outgrowth-stimulating effect was evident 4 h after the addition. The maximum effect was observed at 8 h, and then the effect decreased to the control level at 24 h, indicating that the stimulatory effect of FLPYPY was transient. Thereafter the elongated neurite collapsed to the control level. The effect of FLPYPY was dose-dependent. The percentage measured 4 h after the addition increased progressively (Fig. 3B) . The minimum concentration of the peptide required for stimulation was 10 À9 M, whereas at higher concentrations than 10 À8 M the response reached a plateau. Interestingly, FLPYPY overlaps with the sequence of casoxin B (YPYY, a synthetic peptide corresponding to sequence 79-82 of bovine -casein), which is known as -opioid receptor antagonist.
5) The presence of carboxy terminal two tyrosine residues in casoxin B appears to be important for antagonist activity, since the tripeptide, YPY has no antagonist activity. 5) Hence we examined the effects of FLPYPYY, which contains the full sequence of casoxin B, and FLPYP on neurite outgrowth. FLPYPYY was synthesized by the Yanaihara Institute (Shizuoka, Japan). FLPYPY and FLPYP were prepared from FLPYPYY by hydrolysis with carboxypeptidase A (CPase A, Sigma). FLPYPYY (0.12 mol) was digested with CPase A in 0.2 ml of 50 mM Tris-HCl buffer containing 0.45 M KCl (pH 7.5) at an enzymesubstrate mole ratio of 1=10 5 for 3 to 5 min at 37 C. The reaction was stopped by the addition of 1,10-phenanthroline to a final concentration of 1 mM. The reaction mixture was applied on an ODS column (L-Column ODS, 10 Â 250 mm) with a linear gradient of 10 to 50% acetonitrile containing 0.1% TFA at 2 ml/min. FLPYP, FLPYPY, and FLPYPYY were eluted at about 33%, 35%, and 38% acetonitrile respectively. The eluted peptides were collected separately and evaporated in vacuo. The amino acid sequences of these peptides were confirmed with a protein sequencer. Figure 4 shows the effects of the three peptides on neurite outgrowth 8 h after the addition. FLPYPY produced a significant change at 10 À6 -10 À5 M. Both FLPYP and FLPYPYY were ineffective. A lack of stimulatory activity by these peptides was observed also 4 h after the addition (data not shown). In our previous report, 2) -CMs stimulated neurite outgrowth via -opioid receptors in Neuro-2a cells, and the opioid antagonist alone had no effect. 2) Although the opioid agonist or antagonist activity of FLPYPY is unclear, the neurite outgrowth-stimulating effect of FLPYPY was not reversed by the opioid antagonist, naltrexone (data not shown). Hence the neurite outgrowth-stimulating activity of FLPYPY appeared not to be mediated through opioid receptors in Neuro-2a cells. Further study is required to make clear the mechanism of neurite outgrowth stimulation by FLPYPY.
FLPYPY and -CMs might provide medical or health benefits, including the prevention and treatment of neurodegenerative disease and neuronal injury.
